1-6 of 6
Miguel T Hernández, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Randomized Phase 2 Study of Weekly Carfilzomib 70 Mg/m2 and Dexamethasone Plus/Minus Cyclophosphamide in Relapsed and/or Refractory Multiple Myeloma (RRMM) Patients (GEM-KyCyDex)

Maria-Victoria Mateos, MD PhD, Enrique M. Ocio, MDPhD, Anna Sureda Balari, MD PhD, Albert Oriol, Esther González Garcia, MD, Maria José Moreno, Miquel Granell, MD, Fernando Escalante, MD, Veronica Gonzalez De La Calle, MD PhD, Laura Rosinol Dachs, Estrella Carrillo-Cruz, MD, Joaquín Martínez-López, Maria Victoria Dourdil Sahun, Marta Sonia Gonzalez, MD, Jaime Perez De Oteyza, MDPhD, Felipe De Arriba, PhD, Miguel T Hernández, MD PhD, Aránzazu García Mateo, PhD, Ana Pilar Gonzalez, PhD, Rafael Rios, MD PhD, Carmen Cabrera, Juan Jose Bargay, Paula Rodriguez-Otero, MD, Felipe Casado, Maria Casanova, MD, María Jesús Blanchard, Joan Blade Creixenti, Juan Jose Lahuerta, MD PhD, Jesus F. San-Miguel, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 8–9.
https://doi.org/10.1182/blood-2020-140934
Published: 2020
Journal Articles

Integrated Analysis of Randomized Controlled Trials Evaluating Bortezomib + Lenalidomide + Dexamethasone or Bortezomib + Thalidomide + Dexamethasone Induction in Transplant-Eligible Newly Diagnosed Multiple Myeloma

Laura Rosinol Dachs, Benjamin Hebraud, Albert Oriol, MD, Anne-Laurène Colin, Rafael Rios, MD PhD, Cyrille Hulin, Maria Jesús Blanchard, MD, Denis Caillot, Anna Sureda, MD, Miguel T Hernández, MD PhD, Bertrand Arnulf, Maria-Victoria Mateos, MD PhD, Margaret Macro, Jesús F San-Miguel, MD, Karim Belhadj, Juan Jose Lahuerta, MD PhD, Guang Chen, M. Brigid Garelik, Joan Bladé, MD, Philippe Moreau, Michel Attal, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3245.
https://doi.org/10.1182/blood-2018-99-112659
Published: 2018
Journal Articles

Clinical Significance and Transcriptional Profiling of Persistent Minimal Residual Disease (MRD) in Multiple Myeloma (MM) Patients with Standard-Risk (SR) and High-Risk (HR) Cytogenetics

Ibai Goicoechea, PhD, Noemi Puig, MD PhD, María Teresa Cedena, Lourdes Cordon, Maria-Belen Vidriales, MD, Leire Burgos, Juan Flores-Montero, Norma C. Gutierrez, MD PhD, Maria Jose Calasanz, BSc, PhD, Maria Luisa Martin-Ramos, David Lara-Astiaso, PhD, Amaia Vilas-Zornoza, PhD, Diego Alignani, PhD, Idoia Rodriguez, Sarai Sarvide, Ramon Garcia-Sanz, MD PhD, Joaquin Martinez-Lopez, MD PhD, Albert Oriol, MD, Rafael Rios, MD PhD, Jesús Martín, Rafael Martínez, Josep Sarra, Miguel T Hernández, MD PhD, Javier De La Rubia, MD, Isabel Krsnik, Jose Maria Moraleda, Luis Palomera, MD PhD, Joan Bargay, MD PhD, Alberto Orfao, MD PhD, Laura Rosiñol, Maria-Victoria Mateos, MD PhD, Juan Jose Lahuerta, MD PhD, Joan Bladé, MD PhD, Jesus F San-Miguel, MD PhD, Bruno Paiva, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 112.
https://doi.org/10.1182/blood-2018-99-113312
Published: 2018
Journal Articles

VTD (Bortezomib/Thalidomide/Dexamethasone) As Pretransplant Induction Therapy for Multiple Myeloma: Definitive Results of a Randomized Phase 3 Pethema/GEM Study

Laura Rosinol Dachs, Albert Oriol, MD, Ana Isabel Teruel, MDcal Doctor, Ana López de la Guía, M Jesús Blanchard, Isidro Jarque, Miquel Granell, MD, Antonia Sampol, Luis Palomera, MD PhD, Yolanda Gonzalez-Montes, Enrique Bengoechea, Rafael Martínez-Martínez, Miguel T Hernández, MD PhD, Felipe De Arriba, PhD, Maria Luisa Martin-Ramos, Norma C. Gutierrez, MD PhD, Maria Teresa Cibeira, MD PhD, Maria-Victoria Mateos, MD PhD, Joaquin Martinez-Lopez, MD PhD, Adrián Alegre, MD, Juan Jose Lahuerta, MD PhD, Jesus F San-Miguel, MD PhD, Joan Blade, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 126.
https://doi.org/10.1182/blood-2018-99-111924
Published: 2018
Journal Articles

Early Death in Multiple Myeloma. Analysis of Patients in Real-World Practice

Sunil Lakhwani Lakhwani, Miguel T Hernández, MD PhD, Pablo Lorenzo-Barreto, MDcal Student, Deborah Cabrera-Brito, MDcal Student, Marta Fernández-González, MD PhD, Patricia Machado-Machado, MD, Maribel Díaz-Gómez, MD, Jose Maria Raya Sanchez, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5595.
https://doi.org/10.1182/blood-2018-99-114129
Published: 2018
Journal Articles

Curativestategy (GEM-CESAR) for High-Risk Smoldering Myeloma (SMM): Carfilzomib, Lenalidomide and Dexamethasone (KRd) As Induction Followed By HDT-ASCT, Consolidation with Krd and Maintenance with Rd

Maria-Victoria Mateos, MD PhD, Joaquin Martínez-López, MD PhD, Paula Rodriguez Otero, MD, Enrique M. Ocio, MD, Marta Sonia Gonzalez, MD, Albert Oriol, MD, Norma C. Gutierrez, MD PhD, Bruno Paiva, MD PhD, Rafael Rios, MD PhD, Laura Rosinol, MD PhD, Miguel Angel Alvarez, MD, Maria Jose Calasanz, BSc, PhD, Joan Bargay, MD PhD, Ana Pilar Gonzalez, PhD, Adrián Alegre, MD, Fernando Escalante, MD, Rafael Martínez, Noemi Puig, MD PhD, Javier De La Rubia, MD, Ana Isabel Teruel, MDcal Doctor, María Teresa Cedena, Felipe De Arriba, PhD, Luis Palomera, MD PhD, Miguel T Hernández, MD PhD, Javier Lopez Jimenez, MD PhD, Jesús Martín, Esther Piensa, Aránzazu García Mateo, PhD, Veronica Gonzalez De La Calle, MD PhD, Joan Bladé, MD PhD, Juan Jose Lahuerta, MD PhD, Jesus F San-Miguel, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2142.
https://doi.org/10.1182/blood-2018-99-112656
Published: 2018